Agricultural Crops Plant Science

BioConsortia and H&T Collaborate to Launch FixiN 33 Microbial Seed Treatment in New Zealand

BioConsortia and H&T (Hodder and Taylors Ltd) collaborate to release FixiN 33, a microbial seed treatment for corn, brassicas, and cereals.
Photo by Noah Klimpel on Unsplash

Key Takeaways:

  • Introduction of FixiN 33: BioConsortia and H&T (Hodder and Taylors Ltd) collaborate to release FixiN 33, a microbial seed treatment for corn, brassicas, and cereals.
  • Focus on Efficiency: Aims to optimize nitrogen use, reduce fertilizer runoff, and maintain crop yields.
  • Field Trial Success: Trials in New Zealand align with earlier results from the U.S., Canada, Brazil, and Europe.
  • Long Shelf Life: The treatment offers two years of shelf life and on-seed stability.
  • Localized Approach: Developed using naturally occurring microbes to comply with New Zealand’s regulatory requirements.

Partnership Details

BioConsortia (Profile) has partnered with H&T (Hodder and Taylors Ltd) to launch FixiN 33, a microbial seed treatment designed to help New Zealand farmers optimize nitrogen use. The product will be available for corn, brassicas, and cereals during the 2024/2025 growing season.


Results from Field Trials

Since 2023, BioConsortia and H&T have conducted field trials in New Zealand. These trials demonstrated consistent nitrogen-replacement results, building on previous work in international markets such as the U.S., Canada, Brazil, and Europe.

Paul Oliver, Managing Director of H&T, stated:

“This technology highlights an opportunity to reduce nitrogen fertilizer usage in New Zealand, delivering both economic and environmental benefits while maintaining crop yields.”


Product Features and Research Insights

FixiN 33 uses Gram-positive microbes to colonize plant roots, converting atmospheric nitrogen into plant-usable forms. This approach ensures nitrogen availability throughout the growing season, reducing reliance on synthetic fertilizers.

Marcus Meadows-Smith, CEO of BioConsortia, commented:

“Our proprietary microbes effectively colonize crop roots, providing nitrogen that supports crop yield over the growing season.”

Dr. Hong Zhu, Senior VP of R&D at BioConsortia, added:

“We’ve developed microbes with nitrogen-fixing potential that are effective as seed treatment products, providing reliability and stability for growers.”


Compliance with Local Regulations

To align with New Zealand’s regulatory restrictions on gene-edited organisms, BioConsortia identified wildtype microbes from its library of naturally occurring organisms. These microbes were selected for their genetic traits enabling nitrogen fixation and consistent performance.


Long-Term Product Stability

FixiN 33 offers two years of shelf life and remains stable on seeds for an additional two years. This durability supports flexibility for farmers and distributors in managing their seed inventories.


BioConsortia Recent News

Discover the company in our directory here.

Unveils Promising Field Test Results for SOLVARIX Bionematicide (2024/08/06)

BioConsortia presented field test results for its SOLVARIX bionematicide, demonstrating its potential to reduce ecological impact while maintaining crop productivity. The product demonstrated direct control of nematode pests and increased corn yields by 578 kg/hectare. The bionematicide market in Brazil has expanded from 160 million in 2014 to 1.6 billion in 2021.

BioConsortia Secures $15M In Latest Funding Round (2024/04/02)

BioConsortia, Inc. has recently completed an internal financing round to develop microbial products that enhance crop yields through nitrogen fixation and provide environmentally friendly pest control. The financing, led by Otter Capital, reflects confidence in BioConsortia’s field trials and gene-editing technology. CEO Marcus Meadows-Smith highlighted the success of their nitrogen-fixing seed treatments and expressed plans for expanding field trials and strengthening intellectual property. The investment will also be used to expand BioConsortia’s laboratory facilities in California to accommodate the growing team and upgrade capabilities. Meadows-Smith stated that the company’s products are set to approach commercialization beginning in 2024.

Advances Nitrogen-Fixing Products, Demonstrating Significant Field Trial Success in 2023 (2024/01/21)

BioConsortia has developed nitrogen-fixing products for row crops that can replace nitrogen fertilizers and increase crop yields. The effectiveness of these products was validated in extensive field trials in 2023. The company’s proprietary microbes can remain active in the root zone throughout the growing season, ensuring a continuous supply of nitrogen to the crops. BioConsortia’s nitrogen-fixing seed products remain stable for more than two years, extending their application to in-season side-dress or in-furrow uses. The company is participating in upcoming industry events to showcase its technology and engage with stakeholders.

Develops Nitrogen-Fixing Products (2024/01/29)

BioConsortia, Inc. has developed groundbreaking nitrogen-fixing products that expand the market potential to include new crop opportunities. The 2023 field trial results have been a milestone, demonstrating that their products can effectively replace nitrogen levels in various crops. These products reduce the dependency on synthetic nitrogen fertilizers and enable growers to balance crop productivity with ecological safety more effectively. BioConsortia’s development of nitrogen-fixing products represents a significant advancement in sustainable agriculture, setting a new standard for balancing agricultural productivity with ecological safety.

BioConsortia Expands into Brazil (2023/09/20)

BioConsortia, Inc. has expanded into Brazil, with a significant biological product market valued at over $850 million. This strategic move focuses on introducing advanced microbial products that reduce reliance on synthetic nitrogen fertilizers and provide robust crop protection. The company’s products, which have a long shelf-life and are as effective as chemical alternatives, align with Brazil’s growing adoption of biological products, especially in broadacre crops. With the appointment of Cesar Lamonega and Debora Chaves Coelho Leite to spearhead business development and regulatory affairs and a partnership with Mosaic Company, BioConsortia is poised to enhance its commercial activities in Brazil. This expansion is part of BioConsortia’s broader goal to improve farmer profitability and reduce the ecological impact of agriculture globally, with ongoing field tests in Brazilian corn production to showcase the benefits of their innovative products.

Expands Field Trials & Closes Financing Round (2023/04/19)

BioConsortia, a biotech firm, is conducting an extensive field trials program for its agricultural microbial solutions. The program aims to demonstrate the company’s pipeline, which features solutions for nematodes, nitrogen use, and food waste. The trials will take place in Asia, Latin America, Europe, and North America. BioConsortia relies on commercial partners to bring its products to market. The company closed a financing round and plans to use the funds to expand globally and advance its pipeline.

Image provided by BioConsortia

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

2 Comments

Leave a Reply